Search

everythinglearnresearchcommunity

for

Search:↓

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Nanoparticles added to natural materials like cellulose and collagen can improve cell growth and wound healing, but more testing is needed to ensure they're safe and effective.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

People undergoing chemotherapy need better support and information to cope with hair loss.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Hair transplants can work for frontal fibrosing alopecia and lichen planopilaris, but results are less favorable and the conditions can develop after the transplant.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

There is a significant need for better-validated quality of life tools in dermatology.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Combination therapies work better than single treatments for hair loss.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

Not enough evidence to support using platelet rich plasma for hair loss treatment.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Lupus patients' body image issues significantly affect their mental health and need more support.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.